Clinical trial

Testing of DNA Extracted From Tumor Tissue Biopsy Samples Using Therascreen KRAS RGQ PCR Kit

NCT05360225

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2020-04-02

PhaseN/A

Study timeline

Study start (actual)2020-04-02Date precision: day

Registry last updated2024-11-04

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Non Small Cell Lung Cancerunresolved

Interventions

therascreen® KRAS RGQ PCR KitDIAGNOSTIC_TEST

Sponsors & collaborators

QIAGEN Gaithersburg, Inclead sponsor

Amgencollaborator

Mapped research locations

ManchesterUnited Kingdom1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05360225 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.